Results 91 to 100 of about 4,484,225 (267)

Oral Solid Dosage Forms

open access: yes
Oral drug delivery remains the most popular and convenient way of administering drugs in comparison with the other routes. Advantages include their effectiveness, convenience, less expensive, and non-invasiveness.
Muhamad, Haja   +4 more
core   +1 more source

Dosage Forms

open access: yes, 2023
Dosage forms are pharmaceutical formulation products in the form in which they are presented in the market. They are a crucial component of contemporary pharmaceutical research.

core   +1 more source

Comparative Effectiveness and Safety of Inebilizumab Versus Rituximab in AQP4‐IgG‐Positive NMOSD

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Rituximab (anti‐CD20, RTX) and inebilizumab (anti‐CD19, INE) represent B‐cell‐depleting therapies used for aquaporin‐4 antibody‐positive (AQP4‐IgG+) neuromyelitis optica spectrum disorder (NMOSD); however, direct comparative evidence remains limited.
Jie Lin   +11 more
wiley   +1 more source

Oral Dosage Forms that should not be Crushed or Chewed

open access: yes, 2002
The 2002 update of the Hospital Pharmacy feature “Oral Dosage Forms that Should Not Be Crushed or Chewed” is included with this issue as a wall chart.
John Mitchell
core   +1 more source

Oral controlled release dosage forms

open access: yes, 2012
Tato bakalářská práce je literární rešerší na téma "Perorální formy s řízeným uvolňováním léčiva". Práce je zaměřena na řízené uvolňování aktvní látky z pevných lékových forem,disoluční testy a kinetické modely disolučních profilů.
Cahová, Tereza
core   +1 more source

Long‐Term Efficacy of Immunotherapy in Autoimmune Autonomic Ganglionopathy—A 10‐Year Follow Up Study

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Autoimmune autonomic ganglionopathy (AAG) is a rare but potentially treatable cause of severe autonomic failure. Evidence guiding long‐term immunotherapy, treatment sequencing, and residual autonomic impairment is limited. We evaluated long‐term treatment response, residual autonomic dysfunction, and relapse patterns in patients with
Giacomo Chiaro   +6 more
wiley   +1 more source

MOGAD Is the Most Common Cause of Isolated Optic Neuritis in Children

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objectives The study aimed to characterize the clinical features, etiologies, and outcomes of isolated, first‐time pediatric ON in the post‐MOG‐IgG era. Methods This was a single‐center retrospective cohort study at Texas Children's Hospital of patients diagnosed with first‐time ON between 2018–2024, with follow‐up data collected through 2025.
Chaitanya Aduru   +13 more
wiley   +1 more source

Drug release from matrix tablets: physiological parameters and the effect of food [PDF]

open access: yes, 2014
Introduction: As dissolution plays an important and vital role in the drug-delivery process of oral solid dosage forms, it is, therefore, essential to critically evaluate the parameters that can affect this process. Areas covered: The consumption of
Ali Nokhodchi   +5 more
core   +1 more source

Interaction of Intraprocedural Antiplatelets and Intravenous Thrombolysis in Acute Intracranial Stenting: RESISTANT Registry Subanalysis

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Introduction/Objective Acute intracranial stenting during endovascular thrombectomy (EVT) for ischemic stroke requires intraprocedural antiplatelet therapy (APT) to maintain patency. However, the hemorrhagic risk of combining APT with intravenous thrombolysis (IVT) remains uncertain.
Aaron Rodriguez‐Calienes   +75 more
wiley   +1 more source

Parenteral Suspensions: Stability Enhancing Liquid Dosage Forms [PDF]

open access: yes, 2019
Oral route is the most common preferred route. In market number of drugs are available with solubility problem. It is difficult to prefer oral conventional dosage form other drugs on this less solubility which result in loss bioavailability.
Santosh Kumar, Rada, Tulja Kumari, N.
core   +1 more source

Home - About - Disclaimer - Privacy